NCT00652574 2022-10-31Dasatinib in Resectable Malignant Pleural MesotheliomaM.D. Anderson Cancer CenterPhase 1 Completed56 enrolled
NCT00509041 2016-08-11Dasatinib in Treating Patients With Previously Treated Malignant MesotheliomaAlliance for Clinical Trials in OncologyPhase 2 Completed46 enrolled 14 charts